RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Pharmacokinetics (Pk) and Pharmacodynamics (Pd) and Safety of Artesunate (As) and Dihydroartemisinin (Dha) Following A Single Oral Dose of Artesunate During the 2(Nd) and 3(Rd) Trimester of Pregnancy
Onyamboko, MA., Atibu, J., Lokomba, V., Meshnick, S., Douoguih, M., Hemingway-Foday, J., Koch, M., Wesche, D., Capparelli, E., Fleckenstein, L., Ryder, R., Bose, C., Wright, L., & Tshefu, A. (2009). Pharmacokinetics (Pk) and Pharmacodynamics (Pd) and Safety of Artesunate (As) and Dihydroartemisinin (Dha) Following A Single Oral Dose of Artesunate During the 2(Nd) and 3(Rd) Trimester of Pregnancy. American Journal of Tropical Medicine and Hygiene, 81(5), 224.